The report “Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Immunoassay, NGS, PCR, Microscopy), Application (Diagnostic, Clinical), End User (Pharma, Agriculture & Food Industry, Hospitals, Diagnostic Labs) – Global Forecasts to 2028″, the global life science instrumentation market projected to reach USD 73.9 billion by 2028 from USD 54.9 billion in 2023, at a CAGR of 6.1% from 2023 to 2028. The major factors driving the growth of this market include growing food safety concerns, rising investments in pharmaceutical R&D, increasing public-private investments, and lucrative opportunities in emerging markets.
Don’t miss out on business opportunities in Life Science and Chemical Instrumentation Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
Browse
• 248 Market data Tables
• 47 Figures
• 426 Pages and in-depth TOC on “Life Science Chemical Instrumentation Market – Global Forecast to 2028″
• 248 Market data Tables
• 47 Figures
• 426 Pages and in-depth TOC on “Life Science Chemical Instrumentation Market – Global Forecast to 2028″
Some of the prominent key players are:
- Thermo Fisher Scientific Inc. (US),
- Danaher Corporation (US),
- Agilent Technologies, Inc. (US),
- Waters Corporation (US),
- Shimadzu Corporation (Japan) and many more…..
Spectroscopy segment to register significant growth rate over the forecast period of 2023-2028
Based on the technology, the global life science instrumentation market is segmented into spectroscopy chromatography, Polymerase Chain Reaction (PCR), immunoassays, lyophilization, liquid handling systems, clinical chemistry analyzers, microscopy, flow cytometry, Next-Generation Sequencing (NGS), centrifuges, electrophoresis, cell counting, and other technologies. The NGS segment is anticipated to register the highest growth rate over the forecast period. The spectroscopy segment accounted for the highest share of the life science instrumentation market in 2022.
Research applications segment accounted for the largest share of the life science instrumentation market, by application in 2022.
Based on application, the global life science instrumentation market is segmented into research applications, clinical & diagnostic applications, and other applications. Research applications accounted for the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period. Factors such as the rising incidence of infectious diseases, the growing use of novel analytical techniques, and the launch of advanced instruments drive the growth of life science instruments.
The Asia Pacific market to register the highest growth in the market during the forecast period
The Asia Pacific life science instrumentation market is anticipated to register the highest growth from 2023 to 2028. Major players in the market are focusing on expanding their manufacturing capabilities in the APAC. This region is consistently witnessing a rise in the adoption of analytical instruments, offering significant growth opportunities for the key players.
